Table 1 Socio-demographic and psychiatric characteristics at baseline
|  |  | All participants N = 36 N or M (SD) | MCII group N = 19 N or M (SD) | Control group N = 17 N or M (SD) | p |
|---|---|---|---|---|---|
Gender | male | 25 | 12 | 13 | .39 |
female | 11 | 7 | 4 | Â | |
Main Diagnosis | |||||
 Paranoid Schizophrenia |  | 20 | 12 | 8 |  |
 Persistent Delusional Disorders |  | 1 | 1 | 0 |  |
 Acute and Transient Psychotic Disorders |  | 5 | 2 | 3 |  |
 Schizoaffective Disorders |  | 10 | 4 | 6 |  |
First Episode | Â | 11 | 7 | 4 | Â .39 |
PANSS Negative Score | Â | 19.1 (6.0) | 18.1 (5.7) | 20.2 (6.3) | Â .31 |
BDI-II | Â | 13.8 (8.5) | 16.1 (9.4) | 11.2 (6.9) | Â .09 |
Prescribed Medications | |||||
 Chlorpromazine Equivalent x100mg |  | 7.0 (4.9) | 6.3 (3.5) | 7.9 (6.1) |  .32 |
 SSRIs |  | 3 | 2 |  1 |  |
 Benzodiazepines |  | 7 | 4 |  3 |  |
 Mood Stabilizers |  | 3 | 1 |  2 |  |
 Anticholinergics |  | 7 | 6 |  1 |  |